Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia (Q41200136)

From Wikidata
Jump to navigation Jump to search
scientific article published on 12 February 2015
edit
Language Label Description Also known as
English
Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia
scientific article published on 12 February 2015

    Statements

    Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia (English)
    Christie M Ballantyne
    Joel Neutel
    Anne Cropp
    William Duggan
    Ellen Q Wang
    David Plowchalk
    Kevin Sweeney
    Nitin Kaila
    John Vincent
    Harold Bays
    12 February 2015
    1212-1221

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit